D. E. Shaw & Co., Inc. Stevanato Group S.P.A. Transaction History
D. E. Shaw & Co., Inc.
- $156 Billion
- Q3 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 9,543 shares of STVN stock, worth $210,709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,543
Previous 10,600
9.97%
Holding current value
$210,709
Previous $258,000
5.04%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding STVN
# of Institutions
147Shares Held
53.2MCall Options Held
0Put Options Held
0-
Conestoga Capital Advisors, LLC8.09MShares$179 Million3.35% of portfolio
-
Neuberger Berman Group LLC New York, NY4.87MShares$108 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.55MShares$78.5 Million0.06% of portfolio
-
Times Square Capital Management, LLC3.27MShares$72.2 Million1.35% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.61MShares$57.7 Million0.1% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.84B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...